XIFAXAN 200mg Rx
Generic Name and Formulations:
Rifaximin 200mg; tabs.
Valeant Pharmaceuticals, Inc
Indications for XIFAXAN 200mg:
Travelers' diarrhea due to noninvasive E. coli. Limitations of use: not for use if diarrhea is accompanied by fever or blood in stool, or if causative agent other than E. coli may be suspected (eg, C. jejuni, Shigella spp., Salmonella spp.).
200mg 3 times daily for 3 days.
Discontinue and reevaluate if diarrhea worsens or persists >24–48hrs. Not for treating systemic infections. Severe hepatic impairment (Child-Pugh C). Elderly. Pregnancy. Nursing mothers.
Potentiated by P-gp inhibitors (eg, cyclosporine); caution. Monitor INR and PT with warfarin; dose adjustment may be needed.
Flatulence, headache, abdominal pain, rectal tenesmus, defecation urgency, nausea.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Improving Performance of Everyday Activities Is Critical in Schizophrenia
- Analysis Finds Lithium Maintenance Most Effective as Monotherapy in Bipolar Disorder
- Web-Based Intervention Targets Parental Behaviors That May Affect Adolescent Anxiety, Depression
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Examining Associations Between Diabetes and Effects on Cognition
- Untreated Depression Common in Women of Childbearing Age
- Incidence of Psychiatric Disorders in Rheumatoid Arthritis
- Effect of Antidepressant Class, Dose on Pediatric Anxiety Disorders